Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%

Clinical trial NCT00697541 · COMPLETED

Trial details

NCT number: NCT00697541
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Erythematous Rosacea

Start date: 2008-05-01
Primary completion: 2008-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.